Concepedia

Author

George Sakoulas

University of California San DiegoORCID

Also Known As

G Sakoulas, G. Sakoulas, George Sakoulas

410

Publications

16.3K

Citations

65

H-Index

95

Concepts

All Affiliations

University of California San DiegoWayne State UniversitySharp Memorial HospitalNew York Medical CollegeEugene Applebaum College of Pharmacy and Health Sciences
GS

About

George Sakoulas is an author at University of California San Diego specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

38

53

4.5K

2

Health Sciences

31

39

3.5K

3

Biochemistry

4

4

337

4

Arts

1

1

125

5

Public Health

1

1

18

George Sakoulas

×

143

Publications

11.6K

Citations

61

H-Index

YearCitations

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia

George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag,

Journal of Clinical Microbiology

2004

834

Accessory Gene Regulator ( <i>agr</i> ) Locus in Geographically Diverse <i>Staphylococcus aureus</i> Isolates with Reduced Susceptibility to Vancomycin

George Sakoulas, George M. Eliopoulos, Robert C. Moellering,

Antimicrobial Agents and Chemotherapy

2002

362

Persistent Bacteremia Due to Methicillin‐Resistant<i>Staphylococcus aureus</i>Infection Is Associated with<i>agr</i>Dysfunction and Low‐Level In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein

Vance G. Fowler, George Sakoulas, Lauren M. McIntyre,

The Journal of Infectious Diseases

2004

349

Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Pamela A. Moise-Broder, George Sakoulas, George M. Eliopoulos,

Clinical Infectious Diseases

2004

330

Failures in Clinical Treatment of <i>Staphylococcus aureus</i> Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding

Tiffanny Jones, Michael R. Yeaman, George Sakoulas,

Antimicrobial Agents and Chemotherapy

2007

324

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

Leo Lin, Poochit Nonejuie, Jason Munguia,

EBioMedicine

2015

281

Induction of Daptomycin Heterogeneous Susceptibility in <i>Staphylococcus aureus</i> by Exposure to Vancomycin

George Sakoulas, Jeff Alder, C Thauvin-Eliopoulos,

Antimicrobial Agents and Chemotherapy

2006

261

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

Abhay Dhand, Arnold S. Bayer, Joe Pogliano,

Clinical Infectious Diseases

2011

250

Linezolid Resistance in Sequential<i>Staphylococcus aureus</i>Isolates Associated with a T2500A Mutation in the 23S rRNA Gene and Loss of a Single Copy of rRNA

Venkata G. Meka, Satish K. Pillai, George Sakoulas,

The Journal of Infectious Diseases

2004

248

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

Marin L. Schweizer, Jon P. Furuno, Anthony D. Harris,

BMC Infectious Diseases

2011

246

Page 1